Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4677-4681

  Aparicio, Jorge ^a   Maroto, Pablo ^b   García Del Muro, Xavier ^c   Gumà, Josep ^d   Sánchez Muñoz, Alfonso ^e   Margelí, Mireia ^f   Doménech, Montserrat ^g   Bastús, Romá ^h   Fernández, Antonio ⁱ   López Brea, Marta ^j   Terrassa, Josefa ^k   Meana, Andrés ^l   Martínez Del Prado, Purificación ^m   Sastre, Javier ⁿ   Satrústegui, Juan J ^o   Gironés, Regina ^p   Robert, Lidia ^b   Germà, José R ^c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Idibell Institut Catalá d'Oncologia Duran i Reynals   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g Althaia   (Spain)

^h HOSPITAL MÚTUA DE TERRASSA   (Spain)

ⁱ Unidad de Enfermedades Infecciosas   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^m HOSPITAL DE BASURTO   (Spain)

ⁿ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^o Instituto Oncológico Guipúzcoa   (Spain)

^p HOSPITAL LLUÍS ALCANYÍS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; SEROTONIN 3 ANTAGONIST;

ADULT; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONVALESCENCE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; ORCHIECTOMY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEMINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR VOLUME; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PROSPECTIVE STUDIES; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 83355169744     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.0503     Document Type: Article

References (20)

1. Aparicio J, Díaz R: Management options for stage I seminoma. Expert Rev Anticancer Ther 10: 1077-1085, 2010
2. Chung P, Mayhew LA, Warde P, et al: Management of stage I seminomatous testicular cancer: A systematic review. Clin Oncol (R Coll Radiol) 22:6-16, 2010
3. Oliver RTD, Mead GM, Rustin GJS, et al: Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29:957-962, 2011
4. Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 20:4448-4452, 2002 (Pubitemid 35334756)
5. Aparicio J, Germà JR, García del Muro X, et al: Risk-adapted management for patients with clinical stage I seminoma: The second Spanish Germ Cell Cancer Group study. J Clin Oncol 23:8717-8723, 2005
6. Hermanek P, Sobin LH: International Union Against Cancer: TNM Classification of Malignant Tumours (ed 5). Berlin, Germany, Springer, 1997
7. Arranz Arija J, García del Muro X, Gumà J, et al: E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The Spanish Germ Cell Cancer Group experience. Ann Oncol 12:487-491, 2001 (Pubitemid 32472102)
8. Verdecchia A, Francisci S, Brenner H, et al: Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8:784-796, 2007 (Pubitemid 47321601)
9. Mead GM, Fossa SD, Oliver RT, et al: Randomized trials in 2466 patients with stage I seminoma: Patterns of relapse and follow-up. J Natl Cancer Inst 103:241-249, 2011
10. Zagars GK, Ballo MT, Lee AK, et al: Mortality after cure of testicular seminoma. J Clin Oncol 22:640-647, 2004 (Pubitemid 41095067)
11. Travis LB, Fossa SD, Schonfeld SJ, et al: Second cancers among 40576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 97:1354-1365, 2005
12. Hoffman KE, Chen M-H, Punglia RS, et al: Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol 26:3937-3942, 2008
13. Tarin TV, Sonn G, Shinghal R: Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181:627-633, 2009
14. Powles T, Robinson D, Shamash J, et al: The long term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19:443-447, 2008 (Pubitemid 351336907)
15. Aparicio J, Garcia-Puche J, Lomas M, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance or adjuvant carboplatin: A multivariate analysis on 588 cases. J Clin Oncol 24:229s, 2006 (suppl; abstr 4552)
16. Chung PW, Daugaard G, Tyldesley S, et al: Prognostic factors for relapse in stage I seminoma managed with surveillance: A validation study. J Clin Oncol 28:350s, 2010 (suppl; abstr 4535)
17. Tandstad T, Smaaland R, Solberg A, et al: Management of seminomatous testicular cancer: A binational prospective population-based study from the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA). J Clin Oncol 29:719-725, 2011
18. Aparicio J, García del Muro X, Maroto P, et al: Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 14:867-872, 2003 (Pubitemid 36827202)
19. Dieckmann KP, Brüggeboes B, Pichlmeier U, et al: Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 55:102-106, 2000 (Pubitemid 30050766)
20. Krege S, Beyer J, Souchon R, et al: European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG)-Part I. Eur Urol 53:478-496, 2008